Yaribeygi, H. et al. 2023. Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders. EXCLI Journal. 22, (Apr. 2023), 403–414. DOI:https://doi.org/10.17179/excli2023-6022.